Insulin Resistance and Hyperinsulinemia Are Related to Plasma Aldosterone Levels in Hypertensive Patients
The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—An association between aldosterone and insulin resistance has been demonstrated in obesity and primary aldosteronism and in blacks with the metabolic syndrome. The aim of this study was to evaluate the relationship of plasma aldosterone with insulin sensitivity in white subjects. RESEARCH DESIGN AND METHODS—In 356 patients with essential hypertension and 102 normotensive control subjects of comparable age and BMI, we measured, after discontinuation of treatment, plasma active renin, aldosterone, cortisol, glucose, insulin, and C-peptide levels and calculated markers of insulin sensitivity. Direct assessment of insulin sensitivity was obtained in a subset of 64 hypertensive patients by a hyperinsulinemic clamp. RESULTS—Hypertensive patients had significantly greater fasting plasma insulin and C-peptide concentrations and homeostasis model assessment (HOMA) indexes than normotensive control subjects. A positive association with increasing plasma aldosterone concentrations was demonstrated for plasma glucose, insulin, C-peptides, and HOMA. Assessment of insulin sensitivity by clamp showed a significant decrease of the metabolic clearance rate of glucose with increasing aldosterone levels. Significant correlations were found between plasma aldosterone, plasma insulin, and C-peptide levels, HOMA, and glucose metabolic clearance rate. Blood pressure and plasma potassium, plasma cortisol, and renin levels, but not BMI, were also directly correlated with plasma aldosterone. Multiple regression analysis showed that HOMA, together with plasma potassium, cortisol, and renin levels, was independently correlated with plasma aldosterone. CONCLUSIONS—This study demonstrates a direct relationship between aldosterone, insulin resistance, and hyperinsulinemia in white subjects. In patients with hypertension, this relationship might contribute to maintenance of high blood pressure and increased cardiovascular risk.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Primary aldosteronism (PA) is associated with increased risk for dysglycemia.”
From Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism (2021) · cites this paper as [13]
In the citing paper
“However, the effects of hyperaldosteronism on insulin sensitivity and β-cell function are unclear.”
From Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism (2021) · cites this paper as [13]
In the citing paper
“These assessments do not provide a robust estimation of insulin sensitivity when used alone.”
From Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism (2021) · cites this paper as [13]
In the citing paper
“However, when compared with normotensive cohorts, reduced insulin sensitivity has been reported in PA patients [19,9,20,13,8,21,22].”
From Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism (2021) · cites this paper as [13]
Citations
Cites
Eckel, R. H., Grundy, S. M., & Zimmet, P. Z. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,550
Insulin Resistance in Essential Hypertension
Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, M. A., Oleggini, M., Graziadei, L., Pedrinelli, R., Brandi, L., & Bevilacqua, S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708063170605 · Cited by 2,344
Hyperinsulinemia as an independent risk factor for ischemic heart disease
Després, J.-P., Lamarche, B., Mauriège, P., Cantin, B., Dagenais, G. R., Moorjani, S., & Lupien, P.-J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341504 · Cited by 1,699
Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.
Modan, M., Halkin, H., Almog, S., Lusky, A., Eshkol, A., Shefi, M., Shitrit, A., & Fuchs, Z. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111776 · Cited by 1,465
Triggering and amplifying pathways of regulation of insulin secretion by glucose.
Henquin, J. C. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1751 · Cited by 1,201
Effect of Insulin and Glucose Infusions on Sympathetic Nervous System Activity in Normal Man
Rowe, J. W., Young, J. B., Minaker, K. L., Stevens, A. L., Pallotta, J., & Landsberg, L. (1981) · Diabetes · doi:10.2337/diab.30.3.219 · Cited by 1,143
Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans.
Anderson, E. A., Hoffman, R. P., Balon, T. W., Sinkey, C. A., & Mark, A. L. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115260 · Cited by 1,075
Mulatero (2004) · doi:10.1210/jc.2003-031337 · Cited by 961
The Effect of Weight Loss on the Sensitivity of Blood Pressure to Sodium in Obese Adolescents
Rocchini, A. P., Key, J., Bondie, D., Chico, R., Moorehead, C., Katch, V., & Martin, M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908313210905 · Cited by 621
Serum Aldosterone and the Incidence of Hypertension in Nonhypertensive Persons
Vasan, R. S., Evans, J. C., Larson, M. G., Wilson, P. W. F., Meigs, J. B., Rifai, N., Benjamin, E. J., & Levy, D. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033263 · Cited by 571
Human adipocytes secrete mineralocorticoid-releasing factors
Ehrhart-Bornstein, M., Lamounier-Zepter, V., Schraven, A., Langenbach, J., Willenberg, H. S., Barthel, A., Hauner, H., McCann, S. M., Scherbaum, W. A., & Bornstein, S. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2336140100 · Cited by 443
Racial Differences in the Relation between Blood Pressure and Insulin Resistance
Saad, M. F., Lillioja, S., Nyomba, B. L., Castillo, C., Ferraro, R., De Gregorio, M., Ravussin, E., Knowler, W. C., Bennett, P. H., Howard, B. V., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103143241105 · Cited by 421
Stimulation of the sympathetic nervous system during sucrose feeding
YOUNG, J. B., & LANDSBERG, L. (1977) · Nature · doi:10.1038/269615a0 · Cited by 332
Insulin Resistance/Compensatory Hyperinsulinemia, Essential Hypertension, and Cardiovascular Disease
Reaven, G. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030087 · Cited by 284
Resistant Hypertension, Obesity, Sleep Apnea, and Aldosterone: Theory and Therapy
Goodfriend, T. L., & Calhoun, D. A. (2004) · Hypertension · doi:10.1161/01.hyp.0000116223.97436.e5 · Cited by 279
The renin-angiotensin-aldosterone system, glucose metabolism and diabetes
Giacchetti, G., Sechi, L. A., Rilli, S., & Carey, R. M. (2005) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2005.02.003 · Cited by 267
Self-citationInsulin Sensitivity in Patients with Primary Aldosteronism: A Follow-Up Study
Catena, C., Lapenna, R., Baroselli, S., Nadalini, E., Colussi, G., Novello, M., Favret, G., Melis, A., Cavarape, A., & Sechi, L. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0736 · Cited by 262
Self-citationPlasma aldosterone is independently associated with the metabolic syndrome
Bochud, M., Nussberger, J., Bovet, P., Maillard, M. R., Elston, R. C., Paccaud, F., Shamlaye, C., & Burnier, M. (2006) · Hypertension · doi:10.1161/01.hyp.0000231338.41548.fc · Cited by 226
Association of Adrenal Steroids With Hypertension and the Metabolic Syndrome in Blacks
Kidambi, S., Kotchen, J. M., Grim, C. E., Raff, H., Mao, J., Singh, R. J., & Kotchen, T. A. (2007) · Hypertension · doi:10.1161/01.hyp.0000253258.36141.c7 · Cited by 212
Epoxy-Keto Derivative of Linoleic Acid Stimulates Aldosterone Secretion
Goodfriend, T. L., Ball, D. L., Egan, B. M., Campbell, W. B., & Nithipatikom, K. (2004) · Hypertension · doi:10.1161/01.hyp.0000113294.06704.64 · Cited by 205
Aldosterone as a cardiovascular risk factor
Rossi, G. P., Boscaro, M., Ronconi, V., & Funder, J. W. (2005) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2005.02.010 · Cited by 148
Goodfriend, T. L., Egan, B. M., & Kelley, D. E. (1998) · Endocrine Research · doi:10.3109/07435809809032689 · Cited by 143
Integrins, Vascular Remodeling, and Hypertension
Heerkens, E. H. J., Izzard, A. S., & Heagerty, A. M. (2006) · Hypertension · doi:10.1161/01.hyp.0000252753.63224.3b · Cited by 112
Role for aldosterone in blood pressure regulation of obese adolescents
Rocchini, A. P., Katch, V. L., Grekin, R. J., Moorehead, C., & Anderson, J. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90845-3 · Cited by 112
Aldosterone as a Cardiovascular Risk Factor
Yoo, S. J. (2007) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2007.22.1.8 · Cited by 112
Hyperinsulinemia and the aldosterone and pressor responses to angiotensin II.
Rocchini, A. P., Moorehead, C., DeRemer, S. J., Goodfriend, T. L., & Ball, D. L. (1990) · Hypertension · doi:10.1161/01.hyp.15.6.861 · Cited by 112
Plasma aldosterone, plasma lipoproteins, obesity and insulin resistance in humans
Goodfriend, T. L., Egan, B. M., & Kelley, D. E. (1999) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(99)80020-9 · Cited by 105
Kraus, D., Jäger*, J., Meier, B., Fasshauer, M., & Klein, J. C. (2005) · Hormone and Metabolic Research · doi:10.1055/s-2005-870240 · Cited by 102
Plasma renin and aldosterone measurements in low renin hypertensive states
Sealey, J. E., Gordon, R. D., & Mantero, F. (2005) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2005.02.006 · Cited by 94
Abnormalities of Glucose Metabolism in Patients With Early Renal Failure
Sechi, L. A., Catena, C., Zingaro, L., Melis, A., & De Marchi, S. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1226 · Cited by 91
Self-citationThe effect of aldosterone on glucose metabolism
Corry, D. B., & Tuck, M. L. (2003) · Current Hypertension Reports · doi:10.1007/s11906-003-0065-2 · Cited by 90
Hyperaldosteronism and Hypertension
Grim, C. E., Cowley, A. W., Hamet, P., Gaudet, D., Kaldunski, M. L., Kotchen, J. M., Krishnaswami, S., Pausová, Z., Roman, R., Tremblay, J., et al. (2005) · Hypertension · doi:10.1161/01.hyp.0000154364.00763.d5 · Cited by 88
Insulin hypersecretion: A distinctive feature between essential and secondary hypertension
Sechi, L. A., Melis, A., & Tedde, R. (1992) · Metabolism · doi:10.1016/0026-0495(92)90019-7 · Cited by 80
Self-citationSechi, L. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540450045033 · Cited by 78
Self-citationDELLAMEA, P., LUPIA, M., BANDOLIN, V, GUZZON, S., SONINO, N., VETTOR, R., & FALLO, F. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.08.029 · Cited by 76
Huang, D. Y., Boini, K. M., Osswald, H., Friedrich, B., Artunc, F., Ullrich, S., Rajamanickam, J., Palmada, M., Wulff, P., Kuhl, D., et al. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00299.2005 · Cited by 71
Hypokalemia, glucose intolerance, and hyperinsulinemia during diuretic therapy.
Plavinik, F. L., Rodrigues, C. I., Zanella, M. T., & Ribeiro, A. B. (1992) · Hypertension · doi:10.1161/01.hyp.19.2_suppl.ii26 · Cited by 62
EGAN, B., PAPADEMETRIOU, V, WOFFORD, M., CALHOUN, D., FERNANDES, J., RIEHLE, J., NESBITT, S., MICHELSON, E., & JULIUS, S. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.08.008 · Cited by 50
(2007) · Hypertension · doi:10.1161/01.hyp.0000258652.40768.80 · Cited by 38
effects of insulin on aldosterone production in rat zona glomerulosa cells
Petrasek, D., Jensen, G. M., Tuck, M. L., & Stern, N. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90062-t · Cited by 36
Subcutaneous degradation of insulin
Deckert, T., Hansen, B. S., Lauritzen, T., & Christiansen, J. S. (1981) · Diabetologia · doi:10.1007/bf00251287 · Cited by 28
Haenni, A., Reneland, R., Lind, L., & Lithell, H. (2001) · Journal of Hypertension · doi:10.1097/00004872-200101000-00014 · Cited by 26
Mechanisms of Insulin Resistance Leading to Hypertension: What We Can Learn from Experimental Models
Sechi, L. A., & Bartoli, E. (1997) · Journal of Investigative Medicine · doi:10.1177/108155899704500503 · Cited by 22
Self-citationSechi, L. A. (1997) · American Journal of Hypertension · doi:10.1016/s0895-7061(97)00062-9 · Cited by 17
Self-citationSechi, L. A. (1997) · JAMA · doi:10.1001/jama.277.21.1689 · Cited by 16
Self-citationClausen, J. O., Ibsen, H., Dige‐Petersen, H., Borch-Johnsen, K., & Pedersen, O. B. (1995) · Journal of Hypertension · doi:10.1097/00004872-199505000-00004 · Cited by 9
Perciaccante, A., Fiorentini, A., Valente, R., Stefano, A. D., & Tubani, L. (2007) · Diabetes Care · doi:10.2337/dc07-1176 · Cited by 5
Kotchen, T. A., & Kotchen, J. M. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-3053-9.50010-x · Cited by 2
Cited by
Mechanisms linking obesity to hypertension
Dorresteijn, J. A. N., Visseren, F. L. J., & Spiering, W. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00914.x · Cited by 218
Connell, J. M. C., MacKenzie, S. M., Freel, E. M., Fraser, R., & Davies, E. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0030 · Cited by 182
Hanslik, G., Wallaschofski, H., Dietz, A., Riester, A., Reincke, M., Allolio, B., Lang, K., Quack, I., Rump, L. C., Willenberg, H. S., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0450 · Cited by 155
Inappropriate Left Ventricular Mass in Patients With Primary Aldosteronism
Muiesan, M. L., Salvetti, M., Paini, A., Agabiti-Rosei, C., Monteduro, C., Galbassini, G., Belotti, E., Aggiusti, C., Rizzoni, D., Castellano, M., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.114140 · Cited by 127
Hoppmann, J., Perwitz, N., Meier, B., Faßhauer, M., Hadaschik, D., Lehnert, H., & Klein, J. C. (2009) · Journal of Endocrinology · doi:10.1677/joe-09-0292 · Cited by 131
Metadata
- Authors
- Colussi, G., Catena, C., Lapenna, R., Nadalini, E., Chiuch, A., & Sechi, L. A.
- Affiliations
- University of Udine (IT)
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2007-09-01
- Volume
- 30
- Issue
- 9
- Pages
- 2349-2354
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2109111616
- Cited by
- 155
- References
- 47
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 8 · 2023: 6 · 2022: 7 · 2021: 8 · 2020: 4 · 2019: 7 · 2018: 4 · 2017: 6 · 2016: 6 · 2015: 11 · 2014: 11 · 2013: 9 · 2012: 10
- FWCI
- 8.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System (University of Udine) (submittedVersion)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
- Funders
- Società Italiana dell'Ipertensione Arteriosa
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Keywords
- insulin resistance, hyperinsulinemia, plasma aldosterone, essential hypertension, insulin sensitivity, C-peptide, HOMA, hyperinsulinemic-euglycemic clamp, glucose metabolic clearance rate, renin, cortisol, plasma potassium, cardiovascular risk
- MeSH terms
- Aged, Aldosterone, Cross-Sectional Studies, Female, Glucose, Humans, Hyperinsulinism, Hypertension, Insulin Resistance, Male, Middle Aged
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.